ReviewExperimental & molecular medicine2020

Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity.

Won Suk Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.